Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial
Fayad, Luis, Ansell, Stephen M., Advani, Ranjana, Coiffier, Bertrand, Stuart, Robert, Bartlett, Nancy L., Forero-Torres, Andres, Kuliczkowski, Kazimierz, Belada, David, Ng, Edmund, Drachman, JonathanLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2015.1007504
Date:
February, 2015
File:
PDF, 1.83 MB
english, 2015